Professor | Liming Zhou | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Liming Zhou
Contact Information	1499463946@qq.com
Language ability	Chinese, English
Province	Sichuan

Upload Avatar (500 x 500)

Name

Liming Zhou

Contact Information

1499463946@qq.com

Language ability

Chinese, English

Province

Sichuan

University/Lab Affiliation and Title	Sichuan University
Faculty	West China Institute of Basic Medicine and Forensic Medicine
Academic Background & Achievements	1985 - Bachelor's Degree: West China University of Medical Sciences Master's and Doctoral Degrees: West China University of Medical Sciences 1998-2001 - Visiting Scholar: Harvard Medical School Published over 80 articles, with more than 30 indexed by SCI
Work Experience	Post-1985 - Assistant, Lecturer, Associate Professor, Professor: West China University of Medical Sciences Current - Professor and Doctoral Supervisor: Sichuan University
Awards	Multiple times - Excellent Teaching Quality Award: Sichuan University Awarded - Excellent Innovation and Experiment Education Instructor: Sichuan University

University/Lab Affiliation and Title

Sichuan University

Faculty

West China Institute of Basic Medicine and Forensic Medicine

Academic Background & Achievements

1985 - Bachelor's Degree: West China University of Medical Sciences
Master's and Doctoral Degrees: West China University of Medical Sciences
1998-2001 - Visiting Scholar: Harvard Medical School
Published over 80 articles, with more than 30 indexed by SCI

Work Experience

Post-1985 - Assistant, Lecturer, Associate Professor, Professor: West China University of Medical Sciences
Current - Professor and Doctoral Supervisor: Sichuan University

Awards

Multiple times - Excellent Teaching Quality Award: Sichuan University
Awarded - Excellent Innovation and Experiment Education Instructor: Sichuan University

Areas of Focus	Screening of Antibacterial Drugs and Mechanisms of Drug Resistance Biological Characteristics of Colorectal Cancer Pathogenesis and Molecular Mechanisms of Plant-derived Antitumor Drugs Pharmacological Research of Traditional Chinese Medicine and New Drug Development
Publications	MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer, Yiying Wu, Yi Song, Yao Xiong, Xiaodong Wang, Ke Xu, Bin HanYang Bai, Li Li, Yuanyuan Zhang, Liming Zhou, 2017 Oxyresveratrol prevents murine H22 hepatocellular carcinoma growth and lymph node metastasis via inhibiting tumor angiogenesis and lymphangiogenesis, Yuanqi Liu, Wei Ren, Yang Bai, Lihong Wan, Xiaodong Sun, Yin Liu, Wenbi Xiong, YuanYuan Zhang, Liming Zhou, 2018 NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer, Bin Han, Yuan-Yuan Zhang, Ke Xu, Yang Bai, Li-Hong Wan, Shi-Kun Miao, Ke-Xian Zhang, Hong-Wei Zhang, Yin Liu, Li-Ming Zhou, 2018 Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental data, Rong Li, Xiuying Ma, Yingqi Song, Yuanyuan Zhang, Wen bi Xiong, Li Li, Liming Zhou, 2019 MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer, Ke Xu, Bin Han, Yang Bai, Xiu-Ying Ma, Zhen-Ni Ji, Yao Xiong, Shi-Kun Miao, Yuan-Yuan Zhang and Li-Ming Zhou, 2019 Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses, Li R, Song Y, Ji Z, Li L, Zhou L, 2020 Long intergenic non‑protein coding RNA‑467 targets microRNA‑451a in human colorectal cancer, Yang. Bai, H Wu, Bin, Han, Ke Xu, Yuanqi Liu, Yin Liu, Shikun Miao, Yuanyuan Zhang and Liming Zhou, 2020 Effects of inducing apoptosis and inhibiting proliferation of siRNA on polyadenylate-binding protein-interacting protein1 in tongue cell carcinoma, Huixu Xie, Lisa Yang, Qin Hu, Yingqi Song, Xiaoyi Wang, Liming Zhou, Longjiang Li, 2020 Comparative Transcriptomic Analysis Reveals the Immunosuppressive Targets of Mesalazine in Dextran Sulfate Sodium-Induced Ulcerative Colitis, Rong Li, Lin Cheng, Qi Wang and Liming Zhou, 2021 Mogrol suppresses lung cancer cell growth by activating AMPK-dependent autophagic death and inducing p53-dependent cell cycle arrest and apoptosis, He Li, Linling Liu, Hong-ying Chen, Xin Yan, Ru-li Li, Jie Lan, Kun-yue Xue, Xue Li, Cai-li Zhuo, Lan Lin, Ling-yu Li, Zhuang Wu, Die Zhang, Xue-mei Wang, Wen-jing Huang, Yingling Wang, Wei Jiang, Liming Zhou, 2022 NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK, Hui Liu, Wenqi Lei, Zhigui Li, Xiaodong Wang, Liming Zhou, 2023

Areas of Focus

Screening of Antibacterial Drugs and Mechanisms of Drug Resistance
Biological Characteristics of Colorectal Cancer Pathogenesis and Molecular Mechanisms of Plant-derived Antitumor Drugs
Pharmacological Research of Traditional Chinese Medicine and New Drug Development

Publications

MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer, Yiying Wu, Yi Song, Yao Xiong, Xiaodong Wang, Ke Xu, Bin HanYang Bai, Li Li, Yuanyuan Zhang, Liming Zhou, 2017
Oxyresveratrol prevents murine H22 hepatocellular carcinoma growth and lymph node metastasis via inhibiting tumor angiogenesis and lymphangiogenesis, Yuanqi Liu, Wei Ren, Yang Bai, Lihong Wan, Xiaodong Sun, Yin Liu, Wenbi Xiong, YuanYuan Zhang, Liming Zhou, 2018
NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer, Bin Han, Yuan-Yuan Zhang, Ke Xu, Yang Bai, Li-Hong Wan, Shi-Kun Miao, Ke-Xian Zhang, Hong-Wei Zhang, Yin Liu, Li-Ming Zhou, 2018
Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental data, Rong Li, Xiuying Ma, Yingqi Song, Yuanyuan Zhang, Wen bi Xiong, Li Li, Liming Zhou, 2019
MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer, Ke Xu, Bin Han, Yang Bai, Xiu-Ying Ma, Zhen-Ni Ji, Yao Xiong, Shi-Kun Miao, Yuan-Yuan Zhang and Li-Ming Zhou, 2019
Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses, Li R, Song Y, Ji Z, Li L, Zhou L, 2020
Long intergenic non‑protein coding RNA‑467 targets microRNA‑451a in human colorectal cancer, Yang. Bai, H Wu, Bin, Han, Ke Xu, Yuanqi Liu, Yin Liu, Shikun Miao, Yuanyuan Zhang and Liming Zhou, 2020
Effects of inducing apoptosis and inhibiting proliferation of siRNA on polyadenylate-binding protein-interacting protein1 in tongue cell carcinoma, Huixu Xie, Lisa Yang, Qin Hu, Yingqi Song, Xiaoyi Wang, Liming Zhou, Longjiang Li, 2020
Comparative Transcriptomic Analysis Reveals the Immunosuppressive Targets of Mesalazine in Dextran Sulfate Sodium-Induced Ulcerative Colitis, Rong Li, Lin Cheng, Qi Wang and Liming Zhou, 2021
Mogrol suppresses lung cancer cell growth by activating AMPK-dependent autophagic death and inducing p53-dependent cell cycle arrest and apoptosis, He Li, Linling Liu, Hong-ying Chen, Xin Yan, Ru-li Li, Jie Lan, Kun-yue Xue, Xue Li, Cai-li Zhuo, Lan Lin, Ling-yu Li, Zhuang Wu, Die Zhang, Xue-mei Wang, Wen-jing Huang, Yingling Wang, Wei Jiang, Liming Zhou, 2022
NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK, Hui Liu, Wenqi Lei, Zhigui Li, Xiaodong Wang, Liming Zhou, 2023

Antibacterial Drug Resistance Colorectal Cancer Pathogenesis Plant-Derived Antitumor Molecular Mechanisms Traditional Chinese Medicine Pharmacology New Drug Development

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us